Methods for diagnosing and evaluating cancer
US6680175B2 · kind B2 · utility
5Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 1999 |
| Grant date | Jan 20, 2004 |
| Priority date | — |
| Expiry date | Jan 20, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/915
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for diagnosing cancer, such as prostate, ovarian or breast cancer, as well as leukemia, are provided. Such methods may employ binding agents, such as antibodies or CAR sequences of OB-cadherin or N-cadherin, that specifically bind to OB-cadherin or N-cadherin, or polynucleotides that hybridize to a polynucleotide encoding OB-cadherin or N-cadherin. Also provided are methods for monitoring the progression of a cancer and to evaluate the metastatic potential of a cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.